We have an epidemic in America. We have all seen it on the news. We may even know someone who has...READ MORE
World Diabetes Day a Great Opportunity to Raise Awareness about Potentially Dangerous Medications
When the International Diabetes Foundation started World Diabetes Day in 1991, it created a powerful tool to raise awareness of this disease and to educate people on management and control of the condition. As World Diabetes Day approaches on Nov. 15, the national law firm of Baron & Budd wants to raise awareness of another issue – the dangers associated with certain diabetes drugs, including Invokana, Invokamet, Farxiga and others.
These drugs are part of a class of medications known as SGLT2 (sodium-glucose cotransporter-2) inhibitors. They are designed to help the body remove excess sugar through the process of urination, but they have been linked to diabetic ketoacidosis and kidney damage.
A Dangerous Problem
Our ancestors benefited greatly from SGLT2, which is a protein that helps the body store sugar. Since they did not know where their next meal would come from and were extremely active, our ancestors needed all of the energy their bodies could store. Unfortunately, SGLT2 is not as much of a priority today because many of us are not as active as we need to be. Diabetics have far too much sugar in their bodies, and definitely do not need SGLT2 to work as well as it normally does. As a result, SGLT2 inhibitors keep the protein from functioning and allows the excess sugar to leave the body.
The problem is that SGLT2 inhibitors can cause the development of diabetic ketoacidosis, which develops when high levels of acid are in the bloodstream. This condition occurs when there is an insufficient amount of insulin, a hormone that ensures the body has a proper amount of glucose. When the body notices this problem, it starts to burn fatty acids in response. This, in turn, leads to the development of waste products known as acidic ketone bodies, and ultimately the development of diabetic ketoacidosis. The U.S. Food and Drug Administration issued a Safety Communication in May 2015 linking SGLT2 inhibitors to the condition.
SGLT2 inhibitors include:
- Xigduo XR
SGLT2 inhibitors have also been linked to kidney damage due to an excess amount of waste products in the blood.
As we observe World Diabetes Day, it is important not to forget those who have suffered complications after taking medications that are supposed to help them, not hurt them. If you or a loved one suffered harm after taking an SGLT2 inhibitor, you may be able to take legal action.